Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 8/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.39 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.31 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.31 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.31 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.31 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3460266 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL1031685 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL15603335 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL15603406 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL13697136 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL3359938 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL15603391 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL14416499 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL1031687 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 | |
| SCHEMBL1828824 | 1.00 | CDA (0.42) | CDAPDE4DPDE3ASLC29A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7214791-B2 | Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material | SHENZHEN HANDE TECHNOLOGY CO., LTD. (CN) | 2007-05-08 | — | — | US | disclosed |